This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, X. Q. Articles by Fan, S. T. Search for Related Content PubMed PubMed Citation Articles by Wang, X. Q. Articles by Fan, S. T.

Alternative mRNA Splicing of Liver Intestine-Cadherin in Hepatocellular Carcinoma

¹ Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong and ² Department of Microbiology and Molecular Genetics, University of California, Irvine, California

Requests for reprints: John M. Luk, Department of Surgery, University of Hong Kong, Faculty of Medicine Building LB9-52, 21 Sassoon Road, Pokfulam, Hong Kong. Phone: 852-2819-9628; Fax: 852-2819-9636; E-mail: jmluk{at}hkucc.hku.hk.

Purpose: To identify alternative splicing of the liver intestine-cadherin (LI-cadherin) gene in hepatocellular carcinoma (HCC) and correlate its aberrant expression with clinical outcomes.

Experimental Design: Reverse transcription-PCR (RT-PCR) and quantitative real-time RT-PCR were used to examine alternative mRNA splicing and mRNA level of LI-cadherin in 50 paired tumor-peritumor tissues of 50 HCC and 8 normal liver specimens. The minigene exon-trapping strategy was employed to investigate the splicing mechanism introduced by nucleotide polymorphisms. Association of LI-cadherin splicing with tumor venous infiltration, first-year tumor recurrence, and overall survival after partial hepatectomy were determined.

Results: Alternative mRNA splicing of LI-cadherin was identified in half of the HCC specimens. Sequencing analysis indicated the loss of exon 7 in the spliced LI-cadherin gene. LI-cadherin mRNA was up-regulated from 2.58-fold to 800-fold in over 80% of HCC samples when compared with normal liver by quantitative PCR. Furthermore, nucleotide polymorphisms were identified in putative branch point at IVS6 + 35 (intron 6) as well as in coding sequence 651 (exon 6) in HCC tissues, which may affect alternative mRNA splicing. Clinically, those patients who harbored the alternative splicing of LI-cadherin were strongly associated with shorter overall survival time (P < 0.01) as well as higher incidences of tumor recurrences and venous infiltration (both P < 0.05) after hepatectomy.

Conclusions: Over-expression of LI-cadherin was frequently detected in liver cancer patients. Aberrant alternative splicing of LI-cadherin was detected in 50% of HCC specimens and its clinical significance hinted at early tumor recurrence and poor overall survival of HCC patients.

Key Words: Alternative splicing • LI-cadherin • Hepatocellular carcinoma

This article has been cited by other articles:

				X. Q. Wang, Y. Q. Zhu, K. S. Lui, Q. Cai, P. Lu, and R. T. Poon Aberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma Clin. Cancer Res., November 1, 2008; 14(21): 6813 - 6820. [Abstract] [Full Text] [PDF]

				X. Q. Wang, J. M. Luk, M. Garcia-Barcelo, X. Miao, P. P. Leung, D. W. Ho, S. T. Cheung, B. Y. Lam, C. K. Cheung, A. S. Wong, et al. Liver Intestine-Cadherin (CDH17) Haplotype Is Associated with Increased Risk of Hepatocellular Carcinoma Clin. Cancer Res., September 1, 2006; 12(17): 5248 - 5252. [Abstract] [Full Text] [PDF]

				A. Srebrow and A. R. Kornblihtt The connection between splicing and cancer J. Cell Sci., July 1, 2006; 119(13): 2635 - 2641. [Abstract] [Full Text] [PDF]